Company Search:
Advanced Search
Sponsored Links
GlaxoSmithKline plc - ADR Company Snapshot
GlaxoSmithKline plc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other companies in this sector in UNITED STATES : Sanofi S.A. (2019 sales of $42.06 billion of which 68% was Pharmaceuticals), Novartis AG ($48.62 billion of which 78% was Innovative Medicines), and Merck & Co. , Inc. ($46.84 billion of which 89% was Merck Pharmaceutical).

Sales Analysis. During the year ended December of 2019, sales at GlaxoSmithKline plc were $43.18 billion. This is an increase of 5.3% versus 2018, when the company's sales were $41.01 billion. This was the fourth straight year of sales growth at GlaxoSmithKline plc. Sales of Vaccines saw an increase that was more than double the company's growth rate: sales were up 16.7% in 2019, from $7.84 billion to $9.15 billion. GlaxoSmithKline plc also saw significant increases in sales in Consumer Healthcare (up 12.9% to $11.51 billion) . Not all segments of GlaxoSmithKline plc experienced an increase in sales in 2019: sales of Pharmaceuticals fell 2.3% to $22.45 billion.
  Stock Performance Chart for GlaxoSmithKline plc - ADR
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 40.79
(Figures in U.S. Dollars)
1 Week 1.2%   13 Weeks 2.2%  
4 Weeks -2.7%   52 Weeks 0.8%  
GlaxoSmithKline plc - ADR Key Data:
  Ticker: GSK Country: United States
  Exchanges: NYSE FRA MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 43,176,429,100
(Year Ending Jan 2020).
Employees: 99,437
  Currency: U.S. Dollars Market Cap: 101,021,151,058
  Fiscal Yr Ends: December Shares Outstanding: 2,476,615,618
  Share Type: Ordinary Closely Held Shares: 23,550,117
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.